Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-δ human endometrial adenocarcinoma

Neoplasia

Volumn 2, Issue 6, 2000, Pages 483-490

  Tong, B J ^a   Tan, J ^a   Tajeda, L ^b   Das, S K ^a   Chapman, J A ^a   DuBois, R N ^c   Dey, S K ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclooxygenase; Endometrial cancer; Human; Prostaglandins; Uterus

Indexed keywords

CYCLOOXYGENASE 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RNA;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; BLOTTING, NORTHERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0034485955     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Clinical aspects of risk in women with endometrial carcinoma
2. Epidemiology of endometrial neoplasia
3. Estrogen use-risk of endometrial cancer
4. Preventing endometrial cancers with progestins
5. Estrogen dependency in uterine endometrial cancers
6. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium
7. Eicosanoids and the gastrointestinal tract
8. Prostaglandin endoperoxide H synthase-1 and -2
9. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
10. Cyclooxygenase 1 and 2
11. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids
12. Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua
13. Cancer mortality in patients with rheumatoid arthritis
14. Incidence of cancer among patients with rheumatoid arthritis
15. Sulindac and polyp regression
16. 716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2)
17. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas
18. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
19. Expression of cyclooxygenase-2 in human lung carcinoma
20. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas
21. Expression of cyclooxygenase-2 in human gastric carcinoma
22. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
23. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
24. Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey
25. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation
26. Subcellular localization of prostaglandin endoperoxide synthase-1 and -2 by immunoelectron microscopy
27. Molecular mechanisms of diverse actions of prostanoid receptors
28. The RXR heterodimers and orphan receptors
29. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
30. 2 metabolite binds peroxisome proliferator activated receptor-γ and promotes adipocyte differentiation
31. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
32. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ in a tissue- and inducer-specific manner
33. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
34. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via downregulation of PP2A
35. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor
36. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ
37. Prostacyclin-mediated activation of PPARδ in colorectal cancer
38. PPARδ is a APC-regulated target of nonsteroidal anti-inflammatory drugs
39. Isolation of full-length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloning
40. Expression of transforming growth factor-β isoform (β2 and β3) in the mouse uterus: Analysis of the preimplantation period and effects of ovarian steroids
41. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: A possible ligand for interaction with blastocyst EGF-receptor in implantation
42. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids
43. Adenocarcinoma of the Uterus
44. Effects of Tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma
45. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
46. Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinorna, absence o invasion and concomitant ovarian cancer
47. Cyclooxygenase regulates angiogenesis induced by colon cancer cells